The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced adrenocortical carcinoma from the JAVELIN solid tumor phase Ib trial: Safety and clinical activity.
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Caris MPI; Debiopharm Group; Merck; Novartis
 
Christopher J. Hoimes
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; Prometheus
Research Funding - Merck Sharp & Dohme
 
Corrine Zarwan
Employment - Parexel
Research Funding - EMD Serono; Tesaro
 
Deborah Jean Lee Wong
Research Funding - EMD Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Lilly; Mundipharma
Travel, Accommodations, Expenses - Pharmamar
 
Martin Wermke
Consulting or Advisory Role - Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novartis
 
Rainer Claus
Honoraria - Roche
Consulting or Advisory Role - Gilead Sciences; Janssen-Cilag; Roche
 
Kevin M. Chin
Employment - EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - EMD Serono
 
Anja von Heydebreck
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology